Second quarter net operating income of Dh6 million compared to Dh24 million in Q1 2022 mainly due to lower trading revenues; Net loss attributable to shareholders of Dh170 million in Q2 2022 compared to net income of Dh6 million in Q1 2022
The UAE-based startup eSehati, specialising in offering second opinions for medical treatment, will be expanding in the region by the end of fourth-quarter, said Dr Ahmad Al Amadi, founder, eSehati.
The startup, which went live in December 2020 has close to 700 registered users. “Currently we are on bootstrap mode and the investments are from personal savings. We went ahead and made the investment since there was no single platform exclusively for medical second opinion in UAE and the company was formed to fill that gap. eSehati is the only platform where one can connect with the best Emirati doctors of various specialities,” said Al Amadi.
“Since we are a 100 per cent digital player, geographic boundaries are no constraint for us to spread to other markets. 2021 being the first year for us we prefer to move ahead slowly and by 2022 we will be in hyper growth mode with world’s leading doctors on our platform rendering their services to our customers and we will be ensuring our presence in Asian and US markets.”
eSehati currently has two Covid-19 experts on board Dr Bassam Mahboub (Pulmnologist) and Dr Fatma Mohammed Al Jassim (Pediatric Pulmnologist) where the Covid-19 related queries are answered online.
Al Amadi realised the need in the community for expert advice as patients want trusted second opinions for their conditions specially when they decide to go for major surgery. It also was clear that insurance companies also desperately needed trusted physicians for second opinions before giving approvals for costly procedures. The thought for the need of a platform didn’t happen on a single day. eSehati as a product was a culmination of the thought process over a period of time. The product was test launched on December 2020 among a set of selected physicians and a few of Dr Ahmad’s patients at his clinic, and soft launched in February 2021.
“I believe this is an innovative idea with strategic focus by the management. Most importantly the qualifications and the reputation of the doctors panel that eSehati has onboard makes the business model unique. Another factor is that currently there is no competitor for eSehati in UAE. Also the technologically advanced platform gives an excellent user experience,” said Santhosh Narayanan, chief information officer, eSehati.— sandhya@khaleejtimes.com
Second quarter net operating income of Dh6 million compared to Dh24 million in Q1 2022 mainly due to lower trading revenues; Net loss attributable to shareholders of Dh170 million in Q2 2022 compared to net income of Dh6 million in Q1 2022
The UAE, the company’s largest market, saw high growth in merchant payments processed from domestic consumers at 20 per cent year on year, and payments from international visitors growing 92 per cent
The company's strong balance sheet will support the company’s growth strategy, including investments in digital and technological infrastructure as well as its active merger and acquisition pipeline
The company’s revenue increased 31 per cent to Dh1.041 billion as compared to Dh792 million in first half of 2021 while its operating costs dropped 16 per cent
Kashkari sticks to his view of 3.9% Fed funds rate at end-2022; Evans sees 3.4% policy rate this year; Both push back on market expectation for rate cuts next year; Inflation, employment data to determine size of Sept rate hike
Approval would save time, money on Asian routes; Q2 net profit $100m versus loss of $81m a year ago; Revenue up sharply, but still below Q2 in 2019
The transaction includes solar power projects in Turkey’s Karapanar and Gaziantep regions and a wind power project in Ankara
The five-year contract was awarded by Adnoc Offshore to Adnoc Logistics and Services (Adnoc L&S) and underpins the world-class capabilities within Adnoc’s group companies